IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Vhcp Management II, LLC

Q1 2017 Holdings

Filed 2017-05-12 | 20 holdings | $80.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
BioCryst Pharmaceuticals Inc(BCRX)COM09058V103$51.0M6,071,14263.0%
Ascendis Pharma A/S(ASND)COM04351P101$22.7M811,49228.1%
CytomX Therapeutics Inc(CTMX)COM23284F105$5.0M288,9156.2%
Coherus Biosciences Inc(CHRS)COM19249H103$2.0M95,2762.5%
AveXis IncCOM05366U100$78.7K1,035,6570.1%
DBV TechnologiesCOMF2927N109$18.7K373,6170.0%
Edge Therapeutics IncCOM279870109$17.6K1,933,5820.0%
Ra PharmaceuticalsCOM74933V108$15.4K725,0290.0%
Audentes Therapeutics(BOLDEUR)COM05070R104$7.8K458,8820.0%
Axovant Sciences LtdCOMG0750W104$6.4K429,5900.0%
Acceleron Pharma Inc(XLRN)COM00434H108$4.2K156,8800.0%
Akari Therapeutics PlcCOM00972G108$4.1K369,4900.0%
Arca biopharma IncCOM00211Y100$2.8K1,078,9320.0%
Stemline Therapeutics IncCOM85858C107$2.0K228,1300.0%
Lipocine IncCOM53630X104$1.6K420,0000.0%
Kalvista Pharmaceuticals(KALV)COM483497103$1.6K221,6510.0%
Ocera TherapeuticsCOM67552A108$1.6K1,217,8720.0%
Adverum Biotechnologies Inc(ADVMCHF)COM00773U108$756280,0000.0%
Alcobra LtdCOMM2239P109$211185,1400.0%
Sierra Oncology IncCOM82640U107$200130,7980.0%